Pfizer Covid-19 Vaccine | Page 8 | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
June 28, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, JUNE 28, 2025

Pfizer Covid-19 Vaccine

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Pfizer, Moderna Covid-19 vaccines highly effective after first shot in real-world use, US study shows

The risk of infection fell 90% by two weeks after the second shot, the study of nearly 4,000 US healthcare personnel and first responders found

Pfizer's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Pfizer begins early-stage study of oral Covid-19 drug

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Pfizer to make other vaccines using technology behind its Covid-19 shot

A healthcare worker shows a vial of Pfizer/BioNTech Covid-19 vaccine at a vaccination centre, temporarily set up in a hall of the fair, amid the coronavirus disease pandemic in Cologne, Germany, March 18, 2021. REUTERS/Thilo Schmuelgen
Coronavirus chronicle

We can get most Germans vaccinated by summer's end - BioNTech founder

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Pfizer to delivery 200 mln vaccine doses to EU in second quarter

Photo: Collected.
Coronavirus chronicle

Delaying second Pfizer dose leaves cancer patients at risk - researchers

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Coronavirus chronicle

Pfizer/BioNTech say data suggests vaccine 94% effective in preventing asymptomatic infection

A man walks past a sign outside Pfizer Headquarters in the Manhattan borough of New York City, New York, US, July 22, 2020. Photo:Reuters
Coronavirus chronicle

Pfizer to consider new production sites only after 'pandemic supply phase'

Photo: Collected.
Coronavirus chronicle

Europe to get 4 million more Pfizer/BioNTech Covid-19 shots this month

Photo: Collected.
Coronavirus chronicle

Pfizer wants to make vaccine in India if faster clearance, export freedom assured - sources

A woman holds a small bottle labeled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic/File Photo
Coronavirus chronicle

Pfizer/BioNTech Covid-19 vaccine neutralizes Brazil variant in lab study

Those supply disruption concerns have arisen after the Biden administration announced plans to use the Defense Production Act to boost supplies needed to make Pfizer Inc.’s vaccines.(Mint file photo)
Coronavirus chronicle

Poonawalla warns of delays as US prioritizes Pfizer Covid-19 vaccine

Photo: Collected.
Coronavirus chronicle

Pfizer/BioNTech, Astrazeneca Covid-19 vaccine data encouraging - WHO

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net